US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 27.630
  • +2.200+8.65%
Close Nov 6 16:00 ET
  • 27.630
  • 0.0000.00%
Post 17:24 ET
1.83BMarket Cap-10047P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 1.061M --
-- 2024/Q3 -- / 1.074M --
-- 2024/Q2 2.498M / 854.290K --
-- 2024/Q1 156.000K / 816.670K --
Feb 26, 2024 2023/Q4 4.132M / 855.710K --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.061M--
--2024/Q3-- / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--
Feb 26, 20242023/Q44.132M / 855.710K--

Unlock Free Earnings Estimates

Celldex Therapeutics Earnings Reports

  • Celldex Therapeutics | 10-Q: Quarterly report

    05:07

  • Celldex Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:57

  • Celldex Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 04:13

  • Celldex Therapeutics | 10-K: FY2023 Annual Report

    Feb 26 20:10

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      81.82%

    • Hold

      18.18%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data